Chester County News and Community Website
BERWYN, PA — Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) has reported encouraging results from a minipig Dose Range Finding (DRF) study for Probudur, its long-acting liposomal bupivacaine injection. Designed to provide …
Virpax Pharmaceuticals Announces Positive Results in Study for Long-Lasting Pain Relief Formulation Read More
WEST GROVE, PA — LCH Health and Community Services has resumed its dental services, providing affordable, high-quality oral health care to the local community. The reopening follows a temporary pause …
LCH Health and Community Services Reopens Dental Practice with Bilingual Care Read More
WEST CHESTER, PA — Community Volunteers in Medicine (CVIM), a nonprofit dedicated to providing free healthcare to uninsured workers in Chester County, has announced a $150,000 grant from the Bentley …
Grant Boosts Healthcare Access for Uninsured in Chester County Read More
PHOENIXVILLE, PA – PleoPharma, Inc. recently presented new data from its Phase 1b study on Cannabis Withdrawal Syndrome (CWS) at the American Academy of Addiction Psychiatry’s annual meeting in Naples, …
PleoPharma Showcases Promising Results in Study on Cannabis Withdrawal Syndrome Read More
PHILADELPHIA, PA — The Wistar Institute has unveiled a groundbreaking approach to tackling ovarian cancer, potentially revolutionizing treatment outcomes for the deadliest of gynecological cancers. Led by Nan Zhang, Ph.D., …
Pioneering Discovery by The Wistar Institute Offers New Hope in Ovarian Cancer Treatment Read More
BERWYN, PA — Panavance Therapeutics Inc. has announced groundbreaking findings this week, demonstrating the potential of their investigational drug, misetionamide (GP-2250), to tackle various forms of cancer by directly inhibiting …
Panavance Therapeutics Unveils Promising Data on Misetionamide’s Dual Cancer Targeting Mechanism Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has unveiled encouraging preliminary data from the Phase 1 portion of its OCU410 ArMaDa clinical trial, aimed at treating geographic atrophy (GA) secondary …
Ocugen Reports Promising Results from OCU410 ArMaDa Trial for Geographic Atrophy Read More
HARRISBURG, PA — The American Lung Association‘s 2024 “State of Lung Cancer” report brings a mixed bag of findings for Pennsylvania, revealing both significant strides and critical areas needing attention in …
Pennsylvania’s Battle with Lung Cancer: Progress Unveiled, Challenges Persist in 2024 Report Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has announced a groundbreaking approval of Kebilidi (eladocagene exuparvovec-tneq), marking the first gene therapy sanctioned for the treatment of aromatic L-amino …
Revolutionary Gene Therapy Approved: Kebilidi Offers New Hope for Rare Genetic Disorder Read More
WASHINGTON, D.C. — The U.S. Centers for Disease Control and Prevention (CDC) has reported the first confirmed case of clade I mpox in the United States, identified through laboratory testing …
First Clade I Mpox Case Hits U.S.: CDC Ramps Up Response and Prevention Efforts Read More